XML 47 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Taxes on Earnings (Tables)
 12 Months Ended
Oct. 31, 2020
Income Tax Disclosure [Abstract]  
Schedule of Domestic and Foreign Components of Earnings
The domestic and foreign components of earnings before taxes were as follows:
 For the fiscal years ended October 31
 202020192018
 In millions
U.S.$884 $(1,021)$242 
Non-U.S.2,347 3,544 2,771 
 $3,231 $2,523 $3,013 
Schedule of (Benefit from) Provision for Taxes on Earnings
The provision for (benefit from) taxes on earnings was as follows:
 For the fiscal years ended October 31
 202020192018
 In millions
U.S. federal taxes:   
Current$(24)$(987)$751 
Deferred(68)149 (3,132)
Non-U.S. taxes:   
Current319 386 528 
Deferred164 (3)(563)
State taxes:   
Current23 (160)61 
Deferred(27)(14)41 
 $387 $(629)$(2,314)
Schedule of Differences Between U.S. Federal Statutory Income Tax Rate and HP's Effective Tax Rate
The differences between the U.S. federal statutory income tax rate and HP’s effective tax rate were as follows:
 For the fiscal years ended October 31
 202020192018
U.S. federal statutory income tax rate from operations21.0 %21.0 %23.3 %
State income taxes, net of federal tax benefit1.4 %1.5 %0.5 %
Impact of foreign earnings including GILTI and FDII, net(6.1)%(4.4)%(10.9)%
U.S. Tax Reform enactment
— %(2.6)%(35.8)%
Research and development (“R&D”) credit(0.7)%(1.1)%(0.7)%
Valuation allowances2.3 %(3.7)%(9.3)%
Uncertain tax positions and audit settlements(4.1)%(41.1)%(50.3)%
Indemnification related items— %6.8 %5.2 %
Other, net(1.8)%(1.3)%1.2 %
 12.0 %(24.9)%(76.8)%
Reconciliation of Unrecognized Tax Benefits
A reconciliation of unrecognized tax benefits is as follows:
 For the fiscal years ended October 31
 202020192018
 In millions
Balance at beginning of year$929 $7,771 $10,808 
Increases:  
For current year’s tax positions59 79 66 
For prior years’ tax positions71 172 101 
Decreases:  
For prior years’ tax positions(89)(37)(248)
Statute of limitations expirations(2)(15)(3)
Settlements with taxing authorities(148)(7,041)(2,953)
Balance at end of year$820 $929 $7,771 
Schedule of Significant Components of Deferred Tax Assets and Deferred Tax Liabilities The significant components of deferred tax assets and deferred tax liabilities were as follows:
 As of October 31
 20202019
 In millions
Deferred tax assets:
Loss and credit carryforwards$7,857 $7,856 
Intercompany transactions—excluding inventory509 714 
Fixed assets120 115 
Warranty203 195 
Employee and retiree benefits411 396 
Deferred revenue134 135 
Capitalized research and development203 193 
Intangible assets467 420 
Operating lease liabilities218 — 
Investment in partnership108 14 
Other531 542 
Gross deferred tax assets10,761 10,580 
Valuation allowances(7,976)(7,930)
Total deferred tax assets2,785 2,650 
Deferred tax liabilities:
Unremitted earnings of foreign subsidiaries(60)(27)
Right-of-use assets from operating leases(203)— 
Other(32)(63)
Total deferred tax liabilities(295)(90)
Net deferred tax assets$2,490 $2,560 
Deferred tax assets and liabilities included in the Consolidated Balance Sheets as follows:
 As of October 31
 20202019
 In millions
Deferred tax assets$2,515 $2,620 
Deferred tax liabilities(25)(60)
Total$2,490 $2,560 
Schedule of Deferred Tax Assets for Net Operating Loss Carryforwards As of October 31, 2020, HP had recorded deferred tax assets for net operating loss (“NOL”) carryforwards as follows:
 Gross NOLsDeferred Taxes on NOLsValuation allowanceInitial Year of Expiration
 In millions
Federal$291 $61 $(15)2023
State2,737 174 (61)2020
Foreign26,225 7,378 (7,085)2022
Balance at end of year$29,253 $7,613 $(7,161)
Schedule of Deferred Tax Assets for Various Tax Credit Carryforwards
As of October 31, 2020, HP had recorded deferred tax assets for various tax credit carryforwards as follows:
 CarryforwardValuation
Allowance		Initial
Year of
Expiration
 In millions
U.S. foreign tax credits$35 $(35)2030
U.S. R&D and other credits14 — 2040
Tax credits in state and foreign jurisdictions$321 $(59)2022
Balance at end of year$370 $(94) 
Schedule of Deferred Tax Asset Valuation Allowance and Changes
The deferred tax asset valuation allowance and changes were as follows:
 For the fiscal years ended October 31
 202020192018
 In millions
Balance at beginning of year$7,930 $7,906 $8,807 
Income tax (benefit) expense 74 (339)(897)
Other comprehensive loss (income), currency translation and charges to other accounts(28)363 (4)
Balance at end of year$7,976 $7,930 $7,906